Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Cocrystal Pharma Inc (NQ: COCP )

0.3950 -0.0150 (-3.66%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 1, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 47,657
Open 0.3977
Bid (Size) 0.3900 (39)
Ask (Size) 0.4170 (27)
Prev. Close 0.4100
Today's Range 0.3915 - 0.4175
52wk Range 0.3700 - 1.490
Shares Outstanding 97,469,000
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Recap: Cocrystal Pharma Q1 Earnings
Cocrystal Pharma (NASDAQ:COCP) reported its Q1 earnings results on Wednesday, May 11, 2022 at 08:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Gainers Kiromic BioPharma (NASDAQ:KRBP) stock increased by 12.6% to $0.58 during Friday's after-market session. The market value of their outstanding shares is at $8.9 million. 
Via Benzinga

Performance

YTD
-44.56%
-44.56%
1 Month
-9.82%
-9.82%
3 Month
-27.59%
-27.59%
6 Month
-44.56%
-44.56%
1 Year
-67.08%
-67.08%

More News

Read More
The Daily Biotech Pulse: Ampio Falls On Knee Osteoarthritis Trial Update, AstraZeneca's COVID-19 Antibody Data, CureVac-GSK's Bivalent COVID-19 Vaccine Data
Via Benzinga
Cocrystal Pharma Posts Favorable Preliminary Data From Influenza A Antiviral Candidate Trial
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Cocrystal Pharma To Develop Additional Two Antiviral Drug Candidates For COVID-19
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Cocrystal's COVID-19 Antiviral Candidate Shows Potency Against Omicron Variant
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Cocrystal Pharma Files To Start Human Trial For Protease Inhibitor In COVID-19
Via Benzinga
Exposures Product Safety
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
New COVID-19 Vaccination Mandates Make Rapid COVID Tests More Essential Than Ever
Via FinancialNewsMedia
Exposures COVID-19
California and NYC Order Mandatory COVID-19 Testing Among Municipal Workers
Via FinancialNewsMedia
Exposures COVID-19
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
20 Stocks Moving in Friday's Pre-Market Session
Via Benzinga
Exposures Product Safety
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Cocrystal Pharma Stock Is Trading Higher After COVID-19 Candidate Shows Preclinical Activity Against Delta, Gamma Variants
Via Benzinga
Exposures COVID-19
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
28 Stocks Moving in Friday's Pre-Market Session
Via Benzinga
Cocrystal Pharma's Preclinical Protease Inhibitor Effective Against Original, Two Variant COVID-19 Strains
Via Benzinga
Exposures COVID-19
Target Highly Promising Antiviral Therapeutics with Cocrystal Pharma
Via InvestorPlace
Exposures COVID-19
70 Biggest Movers From Yesterday
Via Benzinga
Mid-Afternoon Market Update: Dow Surges 180 Points; Big 5 Sporting Goods Shares Spike Higher
Via Benzinga
Topics Stocks
Exposures US Equities
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.